Oruka Therapeutics, Inc. · NASDAQ:ORKA

Agarwal Arjun sold 1,587 Oruka Therapeutics, Inc. shares (Form 4)

Traded Jun 22, 2026 · Filed Jun 22, 2026

On Jun 22, 2026, Agarwal Arjun (Senior Vice President, Finance) sold 1,587 Oruka Therapeutics, Inc. shares at an average US$80.95 for US$128K under a trading plan, leaving 15,312 shares. Filed Jun 22, 2026 (Form 4).

Sold
1,587 shares
Price
US$80.95 average (US$80.01 to US$82.15)
Value
US$128K
Holding after
15,312 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Senior Vice President, Finance

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 22, 2026Common StockSale888US$80.0116,011Direct
Jun 22, 2026Common StockSale699US$82.1515,312Direct

Source

View original at SEC

Related